Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

PAC-1-temozolomide combination shows promise for anaplastic astrocytoma

europeanpharmaceuticalreviewMay 05, 2019

Tag: PAC-1-temozolomide , astrocytoma , Drug , cancer , Cell

PharmaSources Customer Service